Trial Profile
Evaluation of Pharmacology and Clinical Response to PF-06700841, in Patients with Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Brepocitinib (Primary)
- Indications Plaque psoriasis
- Focus Pharmacodynamics; Therapeutic Use
- 08 Jun 2017 New trial record